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Two types of immune response may lead to a state of acquired resistance to 
tularemia in the mouse. The first type develops only after infection with strains 
capable of proliferation in vivo, allows survival of the host after challenge with 
strains  of  full  virulence,  and  cannot  be  passively  transferred  by  means  of 
serum. The second type develops after immunization with non-viable antigens 
as well as after infection, protects only against strains of less than full virulence, 
and is readily transferred by means of serum. The available evidence suggests 
that  similar considerations  apply with  respect to  acquired  immunity against 
tularemia in guinea pigs, rabbits, monkeys, and probably man. The rat responds 
differently; this more resistant animal may survive challenge with fully virulent 
strains  after  active immunization  with  non-viable  vaccines,  or  after passive 
transfer of immune serum. 
Immunity of the  second type is accounted for adequately by the action of 
humoral antibody directed against the somatic polysaccharide of the organism 
(1, 2). The first type of immunity, however, does not appear to be associated 
with  serum  antibody,  and  presumably is  dependent  upon  a  state  of altered 
reactivity of the tissues. Similar considerations apply to immunity in brucellosis 
and  tuberculosis  (3-5)  and it has been demonstrated that acquired resistance 
to the latter disease may be transferred by means of phagocytic cells (6). The 
present investigation was undertaken to test the hypothesis that  the immunity 
that is effective against fully virulent strains of Pasteurella  tularensis may be 
transferred by cells. 
Materials and Methods 
M/ce.--Inbred  A/LN strain mice procured from the National Institutes  of Health,  Be- 
thesda, and a Fort Detrick strain (FD) of non-inbred Swiss mice were used. The A/LN mice 
were segregated as to sex and age, and only females  were used as donors or recipients of trans- 
ferred tissues. For experiments not involving tissue transfer, males or females were used in- 
discriminately. 
Baxterial Cultures.--A parent  Jap strain  of P.  tularensis was used for immunization of 
mice. In our hands, this strain had an LDs0 for normal mice of approximately 104 organisms 
by the intraperitoneal route and  108 organisms by the subcutaneous route. The strain was 
grown and maintained on slants of SB agar (7). 
Two strains of P. tularemis were used for challenge. The Schu $4 strain, susceptible to 
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streptomycin, and  the  Schu  $5  strain,  resistant to  streptomycin, were highly virulent for 
mice, guinea pigs, and rabbits. 1 organism constituted 1 I~50 for mice for both of these strains 
by either subcutaneous or intraperitoneal injection. The challenge strains were maintained 
in a lyophilized state. Working stock suspensions were grown first on SB agar and then in a 
modified casein hydrolysate medium similar to that described by Mills et al.  (8). Fresh stock 
suspensions were prepared every 4 to 5 weeks and held at 4 to 6°C.  Dilutions for challenge 
were made in sterile gelatin saline,  containing 0.9 per cent sodium chloride and 0.1 per cent 
gelatin. Virulence  of these challenge strains was checked periodically in rabbits. They were 
considered fully virulent if more than 50 per cent of the rabbits died of tularemia within 10 
days following subcutaneous injection of 5 to 10 organisms. 
The EV-76 strain of Pasteurella pestis,  grown on slants of blood agar base (Difco)  at 21°C 
for 24 hours, was maintained on this medium at 4 to 6°C. 
Immunization  of Donor Mice.--Mice  8 weeks or more old were immunized by infection 
with P. tularemis,  strain yap.  Primary immunization consisted of approximately 5  X  1@ 
organisms injected by the intraperitoneal route. A  booster dose of approximately 5  X  107 
organisms was injected by  the intraperltoneal route 4  to  5 weeks after the primary dose. 
These mice are hereafter referred to as immune mice and their tissues as immune tissues. 
Mice were immunized with a  killed  tularemia vaccine by intraperitoneai injection on  5 
successive days of 0.5 ml doses of a suspension of acetone-killed P. tularensis  strain Schu  $5, 
at a  concentration of 4  X  10  ~° cells per ml.  14 days after the initial series  the  mice  were 
similarly injected with a single booster dose of this vaccine. 
Mice were immunized with P.  pestis  strain EV-76  by  a  subcutaneous injection of ap- 
proximately 1 X  107 viable organisms and 28 days later received 1  X  108  viable organisms 
by the intraperitoneal route. 
Harvest  and  Transfer  of Tissues.--Peritoneal  leucocytes were obtained from immunized 
or normal donor mice 4 to 6 days after an intraperitoneal injection of 1 ml of 0.9 per cent 
saline. Immunized donors received a booster injection of vaccine 2 to 4 days before the saline 
injection. The mice were anesthetized by subcutaneous injections of sodium pentobarbital, 
exsanguinated by cardiac puncture, and the peritoneal cavities injected with 8 ml of Hanks's 
balanced salt solution  (BSS).  The abdomens were kneaded gently and  the suspended cells 
were withdrawn by a syringe and needle. Leucocytes were counted, centrifuged at 500 g for 
5 minutes, and resuspended in fresh, cold BSS to the desired concentration. Recipients were 
injected intraperitoneally with 1 ml of the leucocyte suspension within 6 hours after harvest. 
For the passive transfer of spleen tissue or other reticuloendothelial (RES)  tissue, donor 
mice were anesthetized, exsanguinated, and the organs excised. The organs were immediately 
washed in cold BSS, placed in shallow dishes containing BSS plus 10 per cent horse or bovine 
serum, and minced and teased apart with surgical  scalpels.  Crushing of tissues was carefully 
avoided. Large pieces of debris were removed by filtering  the suspension through a 200 mesh 
stainless steel wire sieve.  The resulting filtrate contained individually suspended cells  and 
aggregates of up to 20 cells per clump. Total cells and leucocytes were counted, centrifuged 
at 500 g for 5 to 10 minutes, and resuspended in cold BSS to the desired concentration. Re- 
cipient mice, 6 to 8 weeks old, were injected intraperitoneally with 1 ml of the tissue suspen- 
sion. 
Viability of the tissues was determined at the time of transfer by suspending cells in 0.9 
per cent saline  containing 1 per cent trypan blue and immediately counting the percentage 
of colorless, and hence viable, cells. 
Measurement  of Resistance  to  Tularemia.--Mice  were challenged intraperitoneally or sub- 
cutaneously with _P. tularensis  and observed for deaths daily for 28 days. Death times and 
survivors were appropriately combined into a  single value,  the mean  reciprocal death  time 
(MRDT), in a  manner similar  to that used by Brownlee and Hamre  (9). Tile  MRDT and WILLIA~  PETER  ALLEN  413 
standard deviation were calculated  for each challenged group.  For example, death times of 
6, 7, 8, 8, 8, 8, 9, 9 days and 2 survivors for a group of 10 mice would have an MRDT equal 
to ~'6 +  ~d: +  ~'~ +  ~'6 +  2/i, or 0.103. The longer the animals survived, the smaller was 
10 
the  MRDT.  It was assumed  from previous  experience that mice surviving 28 days after 
challenge would have a death time of infinity for these experiments.  Differences in resistance 
between  2 groups of animals,  as measured  by MRDT's, were tested for significance by the 
t test (10). 
Hemagglutination Titers.--These were determined  according  to the procedure  of Wright 
and Feinberg  (11), using  sheep erythrocytes sensitized with P. tularensis polysaccharide  as 
the test antigen.  The highest  dilution  of serum producing  a uniformly dispersed pattern of 
erythrocytes was recorded  as the antibody titer. 
EXPERIMENTAL 
Transfer  of Peritoneal Leucocytes.--Leucocytes  from  the  peritoneal  cavities 
of normal  and  immune  FD  mice  were  suspended  in  2  parts  BSS  and  1 part 
normal or immune sermn and injected  intraperitoneally  into groups of normal 
FD  mice.  24 hours later  these  animals plus  recipients  of immune serum were 
challenged  by  the  intraperitoneal  route  with  approximately  135  LD~o of  P. 
tularensis  strain  Schu  $4.  Groups  of untreated  mice  and  immune  mice  were 
challenged  similarly. 
Examination  of stained  preparations  of  the  peritoneal  leucocytes  revealed 
lymphocytes and monocytes in approximately equal numbers,  and less than  1 
per cent  of other leucocyte  types.  No significant differences in cell type or in 
cellular morphology were observed between leucocytes from normal and from 
immune  donors. 
The  ratios  of deaths  to  total  numbers  of mice  challenged  are presented  in 
Table  I  along with  mean reciprocal death  times  (MRDT)  and  their standard 
deviations (s.D.). Using the t  statistic and a probability of error of 0.05,  it was 
determined  that  recipients  of immune  peritoneal  leucocytes were significantly 
more resistant to tularemia than all other groups of recipient mice and untreated 
mice, but were obviously less resistant than immune donor mice. Recipients of 
0.33  ml  of  immune  serum  only  were  not  significantly  more  resistant  than 
recipients of normal serum and normal cells, but were significantly more resist- 
ant than previously untreated mice. In additional experiments this slight resist- 
ance of animals inoculated  with  immune serum was not increased  appreciably 
when the volume of antiserum was increased to 1.0 ml. No animal that received 
immune serum alone survived challenge. 
Three  of 30  recipients  of immune leucocytes  survived  challenge,  and  these 
animals were rechallenged in the same manner after 6 weeks. All animals died 
at the same rate as the normal mice, indicating  that infection had been absent 
or minimal following the initial challenge, since no active immunity developed. 
The  initial  passive  immunity  was  evidently  of  relatively  short  duration  in 
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in mice persisted at least 3 months after recovery from infection with the Jap 
strain of P. tularensis. 
Consideration  was  given  to  the  possibility  that  the  enhanced  resistance  of 
recipient mice resulted from infection with organisms present in the leucocyte 
suspension. However, no colonies of P. tularensis  were cultivated by incubation 
of the immune leucocyte suspension on SB agar plates,  and normal mice failed 
to  show  a  significant  resistance  to  tularemia  24  hours  after  intraperitoneal 
injection of viable Jap strain organisms.  For these reasons the observed resist- 
ance was believed to  be caused by  factors other than an active  immunity. 
TABLE I 
Passive Transfer of Peritoneal Leucocytes 
Recipients received: 
Cells* 
Immune 
Immune 
None 
Normal 
Normal 
None 
Serum~ 
Immune 
Normal 
Immune 
Immune 
Normal 
None 
Immune donor mice ..................... 
Dead/Tested  MRDT (±S.D.)§ 
14/15  0.108  (+0.039) 
13/15  0.141  +0.061) 
15/15  ( 0.191  (+0.015)] 
14/14  ~ 0.192  (+0.023)  / 
12/12  (f0.215  (±0.026)1 ] 
16/16  10.235  (±0.024)j 
o/15  I  o 
* 3.4 X  107 peritoneal leucocytes from immune or normal mice respectively. 
$ 0.33 ml of serum from indicated  donor transferred.  Hemagglutination  titer of immune 
donor serum was 1  : 1280. 
§ Mean of reciprocals of death times and standard  deviation. All mice were challenged 24 
hours after tissues were transferred with  135 L950 of Pasteurella tularensis strain  Schu $4 by 
the intraperitoneal  route.  Data enclosed by brackets  are not significantly different at P  = 
0.05. 
Transfer of Cells from Spleens and Other Organs.--When  it was shown  that 
transfer  of  immune  peritoneal  leucocytes  could  enhance  the  resistance  of 
recipients,  other  tissues  of  the  reticuloendothelial  system  (RES)  of immune 
mice were investigated in a similar manner. These tissues included spleen, liver, 
mesenteric  lymph  nodes,  lung,  and  sternal  bone  marrow.  Resistance  to  tu- 
laremia was increased among recipients of immune spleen tissue and to a  lesser 
degree  among recipients  of lymph node  tissue.  No increase  in  resistance  was 
observed among recipients of other transferred  tissues.  The passively  acquired 
resistance of recipients of immune spleen cells equalled and often exceeded  the 
previously described  resistance  of recipients  of immune peritoneal  leucocytes. 
High  concentrations  of  cells  were  readily  obtained  from  spleen  tissue,  and 
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Spleens removed from immune donors between 5 and 12 days after a booster 
dose of live vaccine were usually 2 to 3  times the size of normal spleens. There- 
after the size of the spleen returned  to normal. The  ability of suspensions of 
spleen tissue to transfer resistance to tularemia appeared to be maximal during 
this  interval  of splenomegaly. 
TABLE II 
Resistance of Recipients of Passively Transferred  Viable  Spleen  Tissue and Serum to Subcu- 
taneous and Intraperitoneal Challenge 
I 
Number of spleen  [  Serum  Dead/ 
cells transferred  I  transferred  Route of challenge*  MRDT (=t=s.D.):~  Tested 
1.8  X  l0  s 
1.8  X  10  s 
0 
1.8  X  l0  s 
1.8  X  l0  s 
0 
Immune § 
Normal 
Immune 
Immune 
Normal 
Immune 
8.4  X  10  7  Immune 
8.4  X  10  7  Normal 
9.2  X  10  7  Immune 
9.2  X  10  7  Normal 
Untreated 
Untreated 
Recipients of immune spleen cells 
Intraperitoneal  6/10 
Intraperitoneal  8/10 
Intraperitoneal  10/10 
Subcutaneous  10/10 
Subcutaneous  10/10 
Subcutaneous  10/10 
Recipients of normal spleen cells 
Intraperitoneal 
Intrapefitoneal 
Subcutaneous 
Subcutaneous 
Intraperitoneal 
Subcutaneous 
10/10 
15/15 
8/8 
8/8 
lO/lO 
8/8 
I 
o.o7o  (±o.o64)~ 
0.093  (±o.o51)J 
0.187  (±0.017) 
I  o.nl  (±0.009) 
{0.124  (±0.015)~1 
(0.131  (±0.059)J 
0.192  (±0.021) 
0.233  (±0.028) 
0.118  (±0.007) 
0.168  (±0.015) 
0.245  (±0.015) 
0.171  (-4-0.009) 
* Mice challenged with 72 LDs0 of Pastenrella  tularensis, strain Schu $5, 3 days after passive 
transfer of tissues or serum. 
:~ Mean of reciprocals of death times and standard deviation. Data enclosed by brackets 
~ere not significantly different, P  =  0.05. 
§ 0.25 ml serum  transferred. Immune homologous mouse serum  had a hemagglutination 
titer of 1:2560. 
In  evaluating  the  resistance  observed in  recipient mice  consideration was 
given  again  to  the  possibility of  active  immunity  developing as  a  result  of 
simultaneous transfer of intracellular, viable P. tularensis.  This possibility was 
apparently eliminated by suspending the spleen cells in BSS containing 100 #g 
of dihydrostreptomycin and 10 units of penicillin per ml, the latter included to 
control other contaminants.  After the cells were  treated with antibiotics and 
washed,  no  viable  P.  tularensis  was  recovered  by  plating,  although  viable 
organisms  were  usually  present  initially.  As  a  further  precaution  against 
infection,  recipients were  treated  with  400  #g  of  streptomycin  per  day  by 
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12 days following transfer of tissues. All other challenge groups were similarly 
treated unless otherwise stated. The streptomycin-resistant Schu $5 strain was 
used for challenge to avoid possible effects of residual streptomycin. 
The experimental data presented in Table II are typical of results obtained 
after challenge of recipients of passively transferred spleen tissue. No significant 
difference was observed between the resistances of recipients of normal spleen 
cells with normal serum and untreated  mice.  By subcutaneous  challenge,  no 
significant  difference  was  observed  between  the  resistance  of  recipients  of 
immune spleen cells and recipients of immune sera, although a decided differ- 
ence in resistance between these groups was observed if challenge was by the 
intraperitoneal route. These results were confirmed in replicate experiments. 
TABLE III 
Passively Transferred Graded Doses of Immune Spleen Cells and Killed Immune Spleen Cells 
Number of spleen cells transferred  Dead/Tested  MRDT (=ks.I).)* 
Recipients of viable immune spleen cells 
1.1  X  l0  s  6/8 
1.1  X  l0  T  10/10 
1.1  X  106  10/10 
0  10/10 
Recipients of killed immune spleen cells~ 
1.1  ×  108  I  9/9  I  0.250 
I  I 
0.095  (±0.065) 
0.153  (±0.015) 
0.215  (±0.024) 
0.245  (±0.015) 
* Mean of reciprocals of death times and standard deviation. Mice were challenged with 
150 ~50 of Pasteurella tularensis, strain Schu $5, by the intraperitoneal route 7 days after 
passive transfer of tissues. 
Cells killed by heating at 56°C for 30 minutes. 
Effect  of Graded  Doses  of Immune  Spleen  Cells.--The  degree  of resistance 
resulting in recipient A/LN mice after the passive transfer of graded doses of 
spleen cells from immune isologous donors is presented in Table III. Resistance 
appeared  to be directly proportional to  the  log10 number of viable, immune 
spleen cells transferred.  Extrapolation of these data suggests that transfer of 
1  billion  or  more  spleen  cells  would  allow  essentially  complete  survival  of 
recipients  after intraperitoneal  challenge.  Transfer of such  large numbers  of 
cells was not  technically feasible.  In order to  protect a  small  percentage of 
recipients completely and consistently against challenge, however, 10  s or more 
spleen  cells  from immune  donors  were  required,  and  in  several experiments 
the survivors in such groups ranged from 10 to 70 per cent. 
Data  presented  in  Table  III also indicate  that  transfer of killed  immune 
spleen cells did not increase the resistance of recipients. In other experiments 
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thawing were also inactive. It would appear that the immunity transmitted by 
phagocytic cells was  associated with only viable tissues,  and hence is not a 
result of humoral antibody. 
The duration of passively acquired resistance to tularemia was investigated 
in inbred, A/LN strain recipients by challenging 1, 3, 7, and 21 days following 
the passive transfer of 1.1 X  108 immune spleen cells. Homologous Fort Detrick 
strain  recipients were compared with isologous A/LN  strain  recipients at  2 
of the 4 intervals. Untreated mice of these 2 strains were previously determined 
to be equally susceptible to similar doses of P.  tularensis administered sub- 
cutaneously or intraperitoneally. The results presented in Table IV indicated 
that the per cent survival among groups of A/LN recipients was approximately 
TABLE IV 
Resistance to Tularemia at Intervals Following Passive Transfer of Spleen Cells  from Immune 
A/LN Donor Mice to Normal A/LN and Fort Derrick Recipient Mice 
Recipients 
A/LN (inbred)  ........ 
F.D. (non-inbred)  ..... 
Untreated (A/LN) .... 
Intervals between transfer and challenge 
1  day 
DJT___  L MROT  
6/8  0.084 
10/10  [ 0.245 
3 days 
7/1010.068 
6/6  ]0.129 
10/10 [ 0.240 
7 days 
D/T  MRDT 
6/8  0.094 
10/10 I 0.245 
21 days 
--__D/T  MRDT 
9/13]o.lo3 
7/7  I o.2a4 
10/10 I 0.24O 
* Ratio of deaths to total number challenged. 
Mean of reciprocals  of death times. Mice challenged with 50 to 150 ~50 doses of Pasteu- 
rella tularensis strain Schu $5, by the intraperitoneal route. 
the same at the 4 intervals tested. All of the Fort Detrick strain of recipients 
succumbed to tularemia after challenges at 3 and 21 days post-transfer. Using 
the MRDT as a measure of resistance, it appeared that by 21 days post-transfer, 
the non-inbred recipients lost nearly all of the resistance demonstrated at 3 
days  post-transfer.  No  such  sharp  decrease  was  noted  in  the  resistance  of 
inbred  recipients  over  the  same  time  period.  This  difference in  resistance 
between isologous and homologous recipients suggests that a tissue transplanta- 
tion immunity or homograft reaction developed in non-inbred recipients. Such 
a  phenomenon could cause early rejection of transferred viable tissues from 
genotypically heterologous mice (12) and thereby reduce the efficiency of the 
resistance mechanism associated with the transferred cells. Proof of this must 
await  further experimentation. 
Transfer of Tissues from Donors Immunized with Other Vaccines.--The trans- 
fer of isologous spleen cells from mice immunized with either non-viable P. 
tularensis or with viable P. pestis vaccines served as controls for the immuniza- 418  IMMUNITY  AGAINST  TULAREMIA 
tion  techniques  used  in  the  previous  experiments.  Donors,  recipients,  and 
previously untreated mice were challenged intraperitoneally with the Schu $5 
strain  on  the  3rd  day post-transfer.  Resistance  was  no  greater among mice 
immunized with viable P. pestis and recipients of spleen tissue and/or serum 
from these animals than it was among untreated mice and, hence, need not be 
described here in detail. As expected, all mice succumbed to tularemia following 
challenge. Only those mice immunized with the non-viable P. tularensis vaccine 
and  recipients of serum  from donors  similarly immunized  died significantly 
later than previously untreated controls (Table V). These results suggest that 
passive transfer of cellular immunity to tularemia was possible only if donors 
were specifically immunized by infection with P. tularensis. 
TABLE  V 
Passive  Transfer  of  Tissues  and Serum from  Donors  Immunized  with  a  Killed,  Whole-Cel 
Pasteurella tularensis Antigen 
Passively transferred:  Dead/Tested  MRDT (:t:s.D.)* 
1.6 X  l0  s spleen cells .....................  10/10  0.225  (4-0.026) 
1.3  X  107 peritoneal leucocytes ............  10/10  0.235  ~4-0.005) 
Donor serum (0.25 ml):~ ...................  10/10  0.188  (4-0.021)§ 
Donor mice ..............................  8/8  0.161  (4-0.011)§ 
Untreated ..............................  10/10  0.240  (4-0.021) 
* Mean  of reciprocals  of death  times and  standard  deviation.  Mice challenged with  82 
LDs0 doses of Pasteurella tularensis by the intraperitonal route 3 days after transfer of tissue. 
:~ Hemagglufination titer of donor serum was 1 : 640. 
§ Significantly different from untreated mice, P  =  0.05. 
DISCUSSION 
The data indicate clearly that immunity to fully virulent strains of P. tularen- 
sis can in fact be transferred to normal animals  by tissues from an immune 
donor.  The  following  results  appear  to  eliminate  the  possibility  that  this 
immunity was a result of active immunization by the simultaneous transfer of 
viable P. tularensis or its antigens:  (a) no viable P. tularensis were recovered 
from antibiotic-treated donor cells,  (b) resistance was  transferred with viable 
spleen cells but not with cells inactivated by freezing and thawing, a procedure 
that is not especially detrimental to P. tularensis,  and  (c)  resistance did not 
persist in non-inbred recipients as long as in isologous recipients. 
A significant percentage of recipients of immune cells survived intraperitoneal 
challenge and as a  group were considerably more resistant than recipients of 
immune  sera.  Following  subcutaneous  challenge,  however,  all  recipients  of 
immune cells  died and were no more resistant than similarly challenged recip- WILLIAM PETER  ALLEN  419 
ients of immune sera. These results might be  explained by postulating  that 
the transferred immune cells tended to remain in the peritoneal cavity or its 
efferent lymphatics. Under these conditions the immune cells would be effective 
against intraperitoneally injected organisms,  but not against challenge at a 
remote site such as the skin. 
In all cases in which a considerable degree of immunity was transferred by 
means of spleen cells, splenomegaly was observed in donor mice. Because this 
splenic  hyperplasia was  evident in  the  gross  only in  mice  immunized with 
infectious P. tularensis it was inferred that, in part, this condition represented 
the host's response to tularemia and was possibly associated with the prolifera- 
tion of immune cells. As the splenomegaly subsided, these cells may have dis- 
seminated  throughout  the  host,  thereby  reducing  the  ratio  of  immune  to 
normal cells in this organ. The resistance of immune donor mice was invariably 
greater than that of recipients of their spleen cells. A certain loss of efficiency 
would be expected for cells that had been removed by mincing an intact organ 
such as the spleen and dispersed into an alien environment such as the peri- 
toneal  cavity of another  host.  This  disadvantage appeared  to  be  partially 
overcome by transferring large numbers of immune cells. In fact, the resistance 
of the recipients was proportional to the number of immune cells transferred. 
Other reticuloendothelial tissue of immune mice besides spleen and peritoneal 
leucocytes might also contain immune cells  but not in sufficient numbers  to 
be detectable by the technique used here. It would be unnecessary, however, 
to postulate that all tissues of mice become immune following a tularemia infec- 
tion. The action of serum antibody would tend to localize the infectious agent 
in the sinuses of  RES  organs  where  they would  be  destroyed  or  rendered 
innocuous by fixed or migrating immune phagocytic cells. 
Tularemia in mice has definite advantages as a  model for study of cellular 
immunity.  Brucellosis and  tuberculosis, frequently used in such studies, are 
chronic or sublethal in most hosts unless infection is  initiated with  massive 
numbers of organisms. In the case of tularemia, however, rapidly progressive 
and  uniformly fatal infections may be  initiated in  normal  mice with small 
numbers of organisms. Antibiotic-resistant and antibiotic-susceptible strains of 
P. tularensis of graded virulence are available, and laboratory personnel may 
be safely and effectively immunized through the use of a  recently developed 
viable vaccine (13,  14). 
SUMMARY 
Acquired resistance to fully virulent strains of P.  tularensis  was passively 
transferred to normal mice by viable spleen cells or peritoneal leucocytes from 
donors that recovered from infection with an attenuated strain of P. tularensis. 
This passively transferred resistance was reflected in survival or delayed death 
after challenge of the recipients. The degree of passively transferred resistance 420  I]~fMUNITY AGAINST  TULAREMIA 
was dependent upon the immune status of the donors and the number of viable 
immune cells transferred.  There were indications  that this resistance persisted 
only as long as the transferred  tissues were compatible with the tissues of the 
recipient.  The  results support  the  hypothesis  that  immunity  of mice  against 
fully virulent  strains of P. tularensis is associated with  an altered state of the 
tissues. 
The author wishes to acknowledge the many helpful suggestions of Dr. George G. Wright 
and the technical assistance of Mr. Richard  D. Wagner. 
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